The consideration of a reverse stock split by NRx Pharmaceuticals is a direct response to maintain NASDAQ listing compliance. Reverse splits often lead to negative investor sentiment as they can be perceived as a measure of last resort for companies struggling to meet exchange listing requirements. This news is likely to cause a short-term decrease in NRXP's stock price due to concerns over the company's financial health and the dilutive effect of reverse splits on existing shareholders.